These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 658461)

  • 1. Tumor immunity.
    Siegel BV; Cohen S
    Fed Proc; 1978 Jul; 37(9):2212-4. PubMed ID: 658461
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mechanism of immunosuppression in tumor-bearing mice--different susceptibility of various immune responses to immunosuppression and macrophage series as targets for immunosuppression (author's transl)].
    Okuda S
    Fukuoka Igaku Zasshi; 1981 Dec; 72(12):687-702. PubMed ID: 7341394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer in immunosuppressed experimental animals and human patients.
    Allison AC
    Johns Hopkins Med J Suppl; 1974; 3():341-51. PubMed ID: 4370940
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular and humoral immunity in tumour bearing animals immunized with erythrocytes.
    Donovan G; Dumitrescu R; Popp I; Maltezeanu G
    Neoplasma; 1971; 18(3):241-9. PubMed ID: 5093945
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymus deprived axenic mice. I. Humoral and cellular immunity after neonatal thymectomy.
    Salomon JC; Benveniste J
    Ann Immunol (Paris); 1974; 125(3):499-506. PubMed ID: 4213503
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.
    Tagliabue A; Boraschi D; McCoy JL
    J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotoxicology studies of sodium arsenate-effects of exposure on tumor growth and cell-mediated tumor immunity.
    Kerkvliet NI; Steppan LB; Koller LD; Exon JH
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):65-79. PubMed ID: 7217861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of heterotransplantation of Marek's disease lymphoma-derived cell lines and MD lymphoma cells to nude mice.
    Kodama H; Matsumoto K; Onuma M; Mikami T; Izawa H
    Jpn J Vet Res; 1980 Apr; 28(1-2):31-5. PubMed ID: 7412066
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune responses to fusion of normal cells and those of tumor-bearing mice].
    Tachibana T
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(12):797-802. PubMed ID: 314526
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice.
    Greenberg AH; Playfair JH
    Clin Exp Immunol; 1974 Jan; 16(1):99-109. PubMed ID: 4143189
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.
    Stutman O; Paige CJ; Figarella EF
    J Immunol; 1978 Nov; 121(5):1819-26. PubMed ID: 712067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Types of cellular antitumor cytotoxicity].
    Lomakin MS; Maĭskiĭ IN
    Vopr Onkol; 1988; 34(12):1422-32. PubMed ID: 2975420
    [No Abstract]   [Full Text] [Related]  

  • 15. Host response during the latent period and the growth of an immunologically induced mouse lymphoma.
    Krüger GR
    Beitr Pathol; 1972 May; 146(2):132-44. PubMed ID: 5068499
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction and inhibition of host immunity to experimental neoplasms. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():62-71. PubMed ID: 4804291
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
    Purves EC
    Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependence of spontaneous delayed hypersensitivity to DNA, antinuclear antibody production and development of glomerulonephritis in NZB mice.
    Zitnan D; Rovenský J; Cebecauer L; Pekárek J; Svejcar J; Kopecký S
    Folia Biol (Praha); 1975; 21(4):234-7. PubMed ID: 1081054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.